Global medical technology firm Smith & Nephew has appointed Graham Baker as chief financial officer.

He formally begins the role on 1 March 2017 when he will also be appointed to the company board as an executive director.

Graham joins from Alvogen, a fast-growing generic pharmaceuticals company, where he is chief financial officer. Alvogen has 35 offices globally across US, Europe and Asia and is owned by the founder and major private equity firms led by CVC and Temasek. 

Olivier Bohuon, chief executive of Smith & Nephew, said: “Graham’s blue-chip experience, deep sector knowledge and extensive exposure to established and emerging markets set him apart as the ideal next chief financial officer for Smith & Nephew.  He has a strong track record of delivering operational excellence and has relevant experience across major finance roles and geographic markets, leading large teams responsible for significant budgets. With his hands-on approach, I have no doubt that he will successfully ensure effective financial stewardship for Smith & Nephew.”